Medicare Enrolled
Dr. Chuansheng Wu, MD
Pulmonary Disease · Alpharetta, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Wu from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wu?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Wu
Dr. Chuansheng Wu is a pulmonary disease specialist in Alpharetta, GA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wu performed 2,105 Medicare services across 1,214 unique beneficiaries.
Between the years covered by Open Payments, Dr. Wu received a total of $16,614 from 61 pharmaceutical and/or device companies across 672 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Wu is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in GA
$16,614 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,105
Medicare services
Top 16% in GA for pulmonary disease
1,214
Unique beneficiaries
$124
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~105 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
432 | $170 | $708 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
256 | $96 | $387 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
210 | $94 | $345 |
| Positive pressure ventilator therapy A therapy procedure that uses a positive pressure ventilator to assist with breathing. |
178 | $48 | $192 |
| Pulmonary gas exchange test A test to examine how well the lungs exchange gases. |
144 | $43 | $170 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
125 | $63 | $233 |
| Expiratory airflow and volume test A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume. |
123 | $21 | $87 |
| Lung volume test using gas dilution or washout A test that measures the amount of air in your lungs by using a gas dilution or washout method. |
119 | $33 | $131 |
| Sleep study in sleep lab (age 6+) An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older. |
119 | $420 | $1,495 |
| Sleep study with continuous airway pressure, age 6+ A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older. |
72 | $496 | $1,928 |
| Sleep study with heart rate and breathing monitoring A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep. |
64 | $70 | $289 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
51 | $139 | $541 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
36 | $27 | $102 |
| Bronchial irrigation and suction for cell collection This procedure uses an endoscope to flush and suction the lung airways in order to collect cells for testing. |
34 | $99 | $481 |
| Spirometry test before and after medication A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication. |
25 | $31 | $125 |
| Lung volume test using sensors A test that measures the amount of air in the lungs using sensors. |
25 | $40 | $164 |
| New patient office visit, complex (60-74 min) | 25 | $168 | $664 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
24 | $68 | $274 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
24 | $138 | $541 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
19 | $126 | $503 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,614
Total received (2018-2024)
Avg $2,373/year across 7 years
Top 13% in GA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
61
Companies
672
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,690 (82.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$2,554 (15.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$369 (2.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,907
2023
$3,378
2022
$1,767
2021
$1,527
2020
$2,490
2019
$1,865
2018
$2,680
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$558
AstraZeneca Pharmaceuticals LP
$334
GlaxoSmithKline, LLC.
$307
ANI Pharmaceuticals, Inc.
$275
Merck Sharp & Dohme LLC
$243
Insmed, Inc.
$171
Boehringer Ingelheim Pharmaceuticals, Inc.
$157
Regeneron Healthcare Solutions, Inc.
$153
Grifols USA, LLC
$116
Actelion Pharmaceuticals US, Inc.
$108
JAZZ PHARMACEUTICALS INC.
$106
Amgen Inc.
$101
HARMONY BIOSCIENCES LLC
$70
Bayer Healthcare Pharmaceuticals Inc.
$44
Mylan Specialty L.P.
$29
Avadel CNS Pharmaceuticals, LLC
$26
Philips North America LLC
$25
United Therapeutics Corporation
$24
Paratek Pharmaceuticals, Inc.
$23
Harmony Biosciences Llc
$20
Hikma Pharmaceuticals USA
$16
Top 3 companies account for 41.3% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$2,716
GlaxoSmithKline, LLC.
$2,118
AstraZeneca Pharmaceuticals LP
$1,683
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,291
Actelion Pharmaceuticals US, Inc.
$1,023
Sunovion Pharmaceuticals Inc.
$818
Insmed, Inc.
$625
Bayer HealthCare Pharmaceuticals Inc.
$467
Grifols USA, LLC
$401
Regeneron Healthcare Solutions, Inc.
$384
JAZZ PHARMACEUTICALS INC.
$374
Teva Pharmaceuticals USA, Inc.
$359
ANI Pharmaceuticals, Inc.
$350
United Therapeutics Corporation
$319
Merck Sharp & Dohme LLC
$314
Merck Sharp & Dohme Corporation
$262
Harmony Biosciences LLC
$232
Janssen Pharmaceuticals, Inc
$204
Intuitive Surgical, Inc.
$186
CSL Behring
$176
Baxter Healthcare
$161
Genentech USA, Inc.
$127
Bayer Healthcare Pharmaceuticals Inc.
$126
Amgen Inc.
$121
Daiichi Sankyo Inc.
$118
EISAI INC.
$117
E.R. Squibb & Sons, L.L.C.
$94
Electromed, Inc.
$91
HARMONY BIOSCIENCES LLC
$91
Mylan Specialty L.P.
$80
Octapharma USA, Inc.
$75
Jazz Pharmaceuticals Inc.
$72
Allergan Inc.
$72
La Jolla Pharmaceutical Company
$63
AbbVie Inc.
$58
Novartis Pharmaceuticals Corporation
$56
Mallinckrodt LLC
$56
IDORSIA PHARMACEUTICALS US INC
$54
Mallinckrodt Hospital Products Inc.
$52
PORTOLA PHARMACEUTICALS, LLC
$48
Vapotherm Inc
$47
Advanced Respiratory, Inc
$46
EMD Serono, Inc.
$41
Inogen, Inc.
$40
Paratek Pharmaceuticals, Inc.
$37
Johnson & Johnson Health Care Systems Inc.
$36
Inspire Medical Systems, Inc.
$32
PORTOLA PHARMACEUTICALS, INC.
$28
Allergan, Inc.
$27
Avadel CNS Pharmaceuticals, LLC
$26
Melinta Therapeutics, LLC
$26
Philips North America LLC
$25
ACADIA Pharmaceuticals Inc
$24
Phadia US Inc.
$21
Harmony Biosciences Llc
$20
PFIZER INC.
$20
Covis Pharma GmBH
$19
UCB, Inc.
$19
Hikma Pharmaceuticals USA
$16
Nabriva Therapeutics, plc
$15
Takeda Pharmaceuticals U.S.A., Inc.
$15
Top 3 companies account for 39.2% of all-time payments
Associated products mentioned in payments ›
(AK6) Vest Therapy · ACTHAR · AIRSUPRA · ALVESCO · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · AirDuo Digihaler · Arikayce · BELSOMRA · BEVYXXA · BOSENTAN · BOSENTAN TABLETS · BREO · BREO ELLIPTA · BREZTRI · BREZTRI AEROSPHERE · CINQAIR · CUTAQUIG · DALVANCE · DAYBUE · DUPIXENT · Da Vinci Surgical System · Esbriet · FASENRA · GIAPREZA · HYQVIA · Hillrom - Life 2000 Ventilation System · Hillrom - Vest System Model 105 Home Care · INJECTAFER · INSPIRE · ImmunoCAP · InogenOne · KEYTRUDA · LONHALA MAGNAIR · LUMRYZ · Lenvima · MAVENCLAD · NUCALA · NUZYRA · Neupro · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPDIVO · OPSUMIT · ORENITRAM · POMPE - DISEASE · PURIFIED CORTROPHIN GEL · Perforomist · ProAir Digihaler · Prolastin-C · Prolastin-C Liquid · QUVIVIQ · Ryaltris · SIVEXTRO · SMARTVEST · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · TAGRISSO · TEFLARO · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · Utibron · Vabomere · WAKIX · WINREVAIR · Wakix · XARELTO · XLSD · XOLAIR · XYREM · XYWAV · Xenleta · Xolair · Xyrem · YUPELRI · Yupelri · ZERBAXA · Zemaira
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (82%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Pulmonary diseases within 10 mi
113
Per 100K population
10.6
County median income
$91,490
Nearest hospital
EMORY JOHNS CREEK HOSPITAL
6.0 mi
6.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Wu is a clinical cardiology specialist, with above-average Medicare volume (top 16% in GA), with low-engagement industry engagement in the top 13% of GA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Wu experienced with critical care, first 30-74 min?
Based on Medicare claims data, Dr. Wu performed 432 critical care, first 30-74 min services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Wu receive payments from pharmaceutical companies?
Yes. Dr. Wu received a total of $16,614 from 61 companies across 672 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wu's costs compare to other pulmonary diseases in Alpharetta?
Dr. Wu's average Medicare payment per service is $124. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wu) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Pulmonary Disease
Common procedures, typical costs, and what industry payments mean in pulmonary disease.
Same specialty & city
Pulmonary Diseases in Alpharetta
Browse pulmonary diseases in Alpharetta ranked by procedure volume and transparency data.
Highest volume
Top Pulmonary Diseases in GA
Pulmonary diseases ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pulmonary Diseases in GA
Which GA pulmonary diseases receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
GlaxoSmithKline, LLC. Payments to Doctors
See all physicians who received payments from GlaxoSmithKline, LLC.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology